Devices › Device types
FDA product code DXZ · class 2 · Cardiovascular
Patch, pledget and intracardiac, petp, ptfe, polypropylene: medical device reports filed with FDA
1,499 reports carry this product code, 1993–2026; 4 brands with a page.
- 1,499
- reports with this product code
- 0% of all MAUDE reports
- 143
- reports, 12 months to August 2026
- 51 in the 12 months before
- 28.3%
- classified as malfunction
- 62.3% across all reports
- 14.3%
- classified as death, as reported
- 0.9% across all reports
Product code DXZ is FDA's classification for "Patch, pledget and intracardiac, petp, ptfe, polypropylene" (cardiovascular panel), a class 2 device. 1,499 medical device reports carry this product code, 0% of the MAUDE database, from August 1993 to August 2026.
143 reports arrived in the 12 months to August 2026, up 180% from 51 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (56.2%), malfunction (28.3%) and death (14.3%). 4 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Edwards Pericardial Patch | 181 | 0 | 83.7% | 9.5% |
| Carpentier-Edwards PERIMOUNT Plus Pericardial Bioprosthesis | 2 | 18 | 8.7% | 1.8% |
| Carpentier-Edwards Perimount Aortic Pericardial Bioprosthesis | 1 | 7 | 7.1% | 3.2% |
| GORE DUALMESH Biomaterial | 1 | 8 | 0.1% | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Synovis Surgical Innovations | 167 | 11.1% |
| Edwards Lifesciences | 165 | 11% |
| Bard Peripheral Vascular | 148 | 9.9% |
| Cryolife | 37 | 2.5% |
| B Braun Surgical | 26 | 1.7% |
| W L Gore & Associates | 22 | 1.5% |
| Cook Biotech | 10 | 0.7% |
| Lemaitre Vascular | 10 | 0.7% |
| Maquet Cardiovascular | 4 | 0.3% |
| Boston Scientific | 3 | 0.2% |
| Maquet Cv | 3 | 0.2% |
| Baxter Healthcare | 2 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Insufficient device problem information | 196 | 13.1% |
| Incomplete or missing packaging | 100 | 6.7% |
| Leak/splashthe device leaked | 78 | 5.2% |
| Device remains implanted | 76 | 5.1% |
| Device operates differently than expectedthe device behaved unexpectedly | 72 | 4.8% |
| Device contamination with chemical or other material | 71 | 4.7% |
| Explanted | 44 | 2.9% |
| Restricted flow rate | 32 | 2.1% |
| Off-label use | 31 | 2.1% |
| Material rupture | 26 | 1.7% |
| Replace | 24 | 1.6% |
| Nonstandard device | 23 | 1.5% |
| Delamination | 22 | 1.5% |
| Fluid/blood leak | 22 | 1.5% |
| Improper or incorrect procedure or method | 20 | 1.3% |
| Material split, cut or torn | 18 | 1.2% |
| Product quality problem | 18 | 1.2% |
| Material distortion | 15 | 1% |
| Missing information | 15 | 1% |
| Hole in material | 14 | 0.9% |
Questions about patch, pledget and intracardiac, petp, ptfe, polypropylene reports
What is product code DXZ?
FDA's classification code for "Patch, pledget and intracardiac, petp, ptfe, polypropylene", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
1,499 reports through August 2026, 143 of them in the latest 12 months.
Which brands appear most often?
Edwards Pericardial Patch (181), Carpentier-Edwards PERIMOUNT Plus Pericardial Bioprosthesis (2), Carpentier-Edwards Perimount Aortic Pericardial Bioprosthesis (1) and GORE DUALMESH Biomaterial (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.